NSE / BSEConsumer Discretionary
β‚Ή700.45-17.20-2.40%
P/E193.0Mkt Capβ‚Ή10.13 K CrEV/EBITDA260.9

Medplus Health Services Limited

P/E193.0Mkt Capβ‚Ή10.13 K CrEV/EBITDA260.9
Company Profile

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing services, as well as contract manufacturing of private-label pharmaceuticals, wellness products, and FMCG goods; and operates diagnostic centres. It distributes its products through retail and online channels. The company was incorporated in 2006 and is based in Hyderabad, India.

Valuation

Market Cap
β‚Ή0.00
β€”
Current Price
β‚Ή0
β€”as of 28 Jul 2026
P/E Ratio
0.0x
β€”
P/B Ratio
0.0x
β€”
EV / EBITDA
0.0x
β€”
EV / Sales
0.0x
β€”
52W High
β‚Ή0
β€”
52W Low
β‚Ή0
β€”
Shares Out
0.00 Cr
β€”

Profitability

Operating Margin
0.0%
β€”
Net Profit Margin
0.0%
β€”
EBITDA Margin
0.0%
β€”

Returns

ROE
0.0%
β€”
ROCE
0.0%
β€”
ROIC %
β€”
β€”
ROA
0.0%
β€”
Dividend Payout
0.0%
β€”

Solvency

Current Ratio
0.0x
β€”
Debt / Equity
0.0x
β€”
Debt / Assets
0.0x
β€”
CFO / Net Profit
0.0x
β€”
Interest Coverage
0.0x
β€”

AI Summary

Indian Stock

Sign up free to view AI insights

Get Started

Rule-based from financial data. Not advice.

Price Historyβ–Ό 21.97% over 1Y
Monthly Returns

Historically, Nov has averaged the highest return (+9.9%); Sep the lowest (-8.1%).

Average from:
YearJanFebMarAprMayJunJulAugSepOctNovDec
2026-0.7%Neutral MonthJan 2026: -0.66%+5.8%Positive MonthFeb 2026: +5.80%-1.1%Neutral MonthMar 2026: -1.13%+3.9%Positive MonthApr 2026: +3.87%+3.2%Positive MonthMay 2026: +3.15%-9.6%Negative MonthJun 2026: -9.64%-13.6%*Negative MonthJul 2026: -13.64%β€”β€”β€”β€”β€”
2025-12.9%Negative MonthJan 2025: -12.88%-1.1%Neutral MonthFeb 2025: -1.12%+6.0%Positive MonthMar 2025: +6.01%+5.5%Positive MonthApr 2025: +5.47%+20.9%Positive MonthMay 2025: +20.88%-7.2%Negative MonthJun 2025: -7.16%+3.4%Positive MonthJul 2025: +3.44%-9.5%Negative MonthAug 2025: -9.47%-10.1%Negative MonthSep 2025: -10.11%+0.8%Neutral MonthOct 2025: +0.81%+6.0%Positive MonthNov 2025: +5.95%-0.3%Neutral MonthDec 2025: -0.26%
2024-4.6%Negative MonthJan 2024: -4.57%-3.0%Negative MonthFeb 2024: -2.96%-0.9%Neutral MonthMar 2024: -0.90%+1.1%Neutral MonthApr 2024: +1.15%+4.9%Positive MonthMay 2024: +4.93%-6.9%Negative MonthJun 2024: -6.87%-0.2%Neutral MonthJul 2024: -0.23%+0.3%Neutral MonthAug 2024: +0.29%-1.7%Neutral MonthSep 2024: -1.68%-0.3%Neutral MonthOct 2024: -0.34%+17.0%Positive MonthNov 2024: +17.01%+6.4%Positive MonthDec 2024: +6.40%
2023+3.3%Positive MonthJan 2023: +3.30%+4.7%Positive MonthFeb 2023: +4.67%-2.1%Negative MonthMar 2023: -2.13%+13.6%Positive MonthApr 2023: +13.58%+9.1%Positive MonthMay 2023: +9.09%-4.9%Negative MonthJun 2023: -4.88%+24.3%Positive MonthJul 2023: +24.26%-15.2%Negative MonthAug 2023: -15.24%-4.9%Negative MonthSep 2023: -4.88%+2.5%Positive MonthOct 2023: +2.46%+0.9%Neutral MonthNov 2023: +0.86%-5.4%Negative MonthDec 2023: -5.44%
2022+4.9%Positive MonthJan 2022: +4.91%-5.9%Negative MonthFeb 2022: -5.91%-1.1%Neutral MonthMar 2022: -1.06%-1.4%Neutral MonthApr 2022: -1.45%-13.5%Negative MonthMay 2022: -13.53%-11.5%Negative MonthJun 2022: -11.45%-2.9%Negative MonthJul 2022: -2.93%-0.7%Neutral MonthAug 2022: -0.68%-15.9%Negative MonthSep 2022: -15.87%-4.2%Negative MonthOct 2022: -4.21%+15.6%Positive MonthNov 2022: +15.61%-10.1%Negative MonthDec 2022: -10.14%
2021β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”
AvgΒ±SD-2.0%Β±6.4%+0.1%Β±4.5%+0.2%Β±3.0%+4.5%Β±5.1%+4.9%Β±11.1%-8.0%Β±2.3%+2.2%Β±12.4%-6.3%Β±6.4%-8.1%Β±5.4%-0.3%Β±2.5%+9.9%Β±6.7%-2.4%Β±6.1%
* Current month β€” value will change until month-end.

Each cell is the percentage change in closing price from the end of the prior month to the end of this month. The bottom row shows the average return for that calendar month across the selected years, plus or minus one standard deviation β€” the range that historically contained roughly two-thirds of outcomes. Past monthly patterns are not a forecast of future returns.

Seasonal Tendency

This aggregates every month by calendar position β€” all Januaries together, all Februaries together, and so on β€” to show whether a given month has leaned positive or negative historically. β€˜Simple’ counts each month as +1 or βˆ’1. β€˜Weighted’ gives larger moves more influence: +2 above +10%, βˆ’2 below βˆ’10%. With only 6 years of history for this asset, each month’s score reflects a small number of observations β€” read it as a historical tendency, not a reliable seasonal pattern.

Historical Trend

This tracks a running tally across the asset’s full price history: each month adds or subtracts based on whether it was positive or negative. A rising line means more positive months than negative so far; a flattening or falling line means recent months have leaned negative. This measures historical month-to-month consistency, not expected future performance.

Year-to-Date ROI
Average from:
SD Γ—
Latest: 0.869x (2026)

Year-to-date return is calculated by dividing each day’s closing price by the price on January 1st of that year (or the asset’s first available price if it began trading mid-year). The custom average line shows the mean YTD return at each calendar day across the selected years. The standard deviation band shows the range within which returns have historically fallen β€” at 1 SD, roughly two-thirds of years; at 2 SD, roughly 95%. Past year-to-date patterns do not predict future returns. The average and standard deviation band are computed from the year set chosen in β€œAverage from”, which is independent of which year lines are displayed. The current in-progress year is excluded from these calculations, since a partial year is not comparable to complete ones. Election-cycle groupings follow the US presidential calendar and are offered only for US and crypto assets.

Historical Performance

Revenue, profitability, and cash flow trends (β‚Ή Crores)

Revenue (10Y)

Operating Income (10Y)

Net Profit (10Y)

Operating Margin % (10Y)

Dividend Payout % (10Y)

Free Cash Flow (10Y)

Growth Summary

Latest fiscal year: Mar 2025

Revenueβ‚Ή713.00 Crβ–² 52.7%
EBITDA Growthβ€”
Net Profitβ‚Ή40.00 Crβ–² 344.4%
Cash from Ops (CFO)β€”
Free Cash Flow (FCF)β€”β–Ό 90.9%
Revenue CAGR 5Y50.2%
EBITDA CAGR 5Y0.0%
Net Profit CAGR 5Y0.0%
NP Growth 1Y344.4%

Historical Growth

Year-by-year revenue, profitability, and cash flow (β‚Ή Crores, last 10 years)

YearRevenueOp. IncomeNet ProfitCFOFCFROERev Growth 1YNP Growth 1Y
Mar 2025β‚Ή713.00 Crβ€”β‚Ή40.00 Crβ€”β€”3.2%52.7%344.4%
Mar 2024β‚Ή467.00 Crβ€”β‚Ή9.00 Crβ€”β€”0.8%118.2%50.0%
Mar 2023β‚Ή214.00 Crβ€”β‚Ή6.00 Crβ€”β€”0.5%46.6%0.0%
Mar 2022β‚Ή146.00 Crβ€”β‚Ή6.00 Crβ€”β€”0.5%114.7%-166.7%
Mar 2021β‚Ή68.00 Crβ€”β‚Ή-9.00β€”β€”-1.7%11.5%-64.0%
Mar 2020β‚Ή61.00 Crβ€”β‚Ή-25.00β€”β€”-6.3%510.0%733.3%
Mar 2019β‚Ή10.00 Crβ€”β‚Ή-3.00β€”β€”-1.6%11.1%-81.3%
Mar 2018β‚Ή9.00 Crβ€”β‚Ή-16.00β€”β€”-8.6%350.0%700.0%
Mar 2017β‚Ή2.00 Crβ€”β‚Ή-2.00β€”β€”-2.3%0.0%-50.0%
Mar 2016β‚Ή2.00 Crβ€”β‚Ή-4.00β€”β€”-3.7%0.0%-20.0%

Financial Statements

Income statement, balance sheet, and cash flow (β‚Ή Crores, as reported)

Consolidated Figures in USD Millions.

Unnamed: 0Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue / Net Sales2229106168146214467713768
Total Expenses67414138677142208435635675
EBIT / Operating Profit-3-5-2-5-3-25-936327894
OPM %-137%-225%-89%-52%-36%-41%-13%2%3%7%11%12%
Other Income-110112210237910
Finance Costs1001200137899
Depreciation & Amortisation0000011515242727
Profit Before Tax-5-4-2-16-3-24-96875168
Tax %0%0%0%0%0%2%0%0%27%-36%21%-
Net Profit / PAT-5-4-2-16-3-25-96694053
EPS (β‚Ή)-292.30-241.71-109.61-793.71-126.23-1,220.91-186.950.470.460.793.374.38
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%-

Peer Comparison

Consumer Discretionary sector peers, ranked by market cap

CompanyMarket CapRevenueP/EP/BEV/EBITDARev G 1Y
Medplus Health Services Limitedthis co.β‚Ή10.13 K Crβ‚Ή713.00 Cr193.007.95260.9252.7%
Titan Company Limitedβ‚Ή3.76 L Crβ‚Ή54.84 K Cr96.6021.0969.4916.4%
Eternal Limitedβ‚Ή2.84 L Crβ‚Ή8.62 K Cr120.007.95193.9130.1%
Avenue Supermarts Limitedβ‚Ή2.49 L Crβ‚Ή57.79 K Cr79.8010.4657.8616.7%
Trent Ltd [Lakme Ltd]β‚Ή1.39 L Crβ‚Ή16.67 K Cr82.4021.0949.0239.8%
Marico Limitedβ‚Ή98.15 K Crβ‚Ή7.58 K Cr52.3019.3863.518.3%
SWIGGY LIMITEDβ‚Ή96.87 K Crβ‚Ή8.80 K Crβ€”7.26-63.9238.0%
Industry Averageβ€”β‚Ή4.70 K Cr80.047.9662.2524.3%

Learn while you research

Hand-picked academy chapters to deepen your understanding of Medplus Health Services Limited and the metrics that matter.

Browse the full Equiscale Academy